BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23549837)

  • 21. Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS.
    Dou M; Zhou X; Li L; Zhang M; Wang W; Wang M; Jing Y; Ma R; Zhao J; Zhu L
    Front Immunol; 2021; 12():640778. PubMed ID: 33912166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
    Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.
    O'Sullivan JB; Ryan KM; Harkin A; Connor TJ
    J Neuroimmunol; 2010 Mar; 220(1-2):34-42. PubMed ID: 20061033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS.
    Dai H; Ciric B; Zhang GX; Rostami A
    Immunol Res; 2011 Dec; 51(2-3):145-52. PubMed ID: 22095543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration.
    Niu X; Sang H; Wang J
    J Nutr Biochem; 2021 Mar; 89():108560. PubMed ID: 33249188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.
    Doerck S; Göbel K; Weise G; Schneider-Hohendorf T; Reinhardt M; Hauff P; Schwab N; Linker R; Mäurer M; Meuth SG; Wiendl H
    PLoS One; 2010 Nov; 5(11):e15478. PubMed ID: 21085578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
    Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
    Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.
    Mueller AM; Yoon BH; Sadiq SA
    J Biol Chem; 2014 Aug; 289(33):22888-22899. PubMed ID: 24973214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis.
    Pyka-Fościak G; Lis GJ; Litwin JA
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice.
    Wang J; Qi Y; Niu X; Tang H; Meydani SN; Wu D
    J Nutr Biochem; 2018 Apr; 54():130-139. PubMed ID: 29331869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
    Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis.
    Dopp JM; Breneman SM; Olschowka JA
    J Neuroimmunol; 1994 Oct; 54(1-2):129-44. PubMed ID: 7523443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.